These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 506277)

  • 21. [Cardio-vascular pathology].
    Cah Coll Med Hop Paris; 1969 Dec; 10(17):1367-84. PubMed ID: 5379869
    [No Abstract]   [Full Text] [Related]  

  • 22. Calcium antagonists and cardiovascular disorders.
    Krikler DM
    Ann Cardiol Angeiol (Paris); 1984 Dec; 33(8):513-8. PubMed ID: 6241445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Characteristics of the treatment of ischemic heart disease with delayed-action verapamil].
    Zharov EI; Styrova TK; Barinov VG; Martynov AI; Galichenko IV; Sedov VP; Vertkin AL
    Klin Med (Mosk); 1991 Aug; 69(8):48-50. PubMed ID: 1791709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the effect of verapamil on the tolerance for exertion in coronary patients].
    Miraglia G; Stritoni P; Egloff C; Scattolin G; Contessotto F; Passarin N; Dalla Volta S
    Boll Soc Ital Cardiol; 1979; 24(5):583-9. PubMed ID: 553643
    [No Abstract]   [Full Text] [Related]  

  • 25. [Role of calcium antagonists in the treatment of cardiovascular diseases].
    Akhmedkhanov SSh; Pomerantsev VP; Vasiuk IuA; Mdinaradze IuS
    Sov Med; 1985; (3):44-51. PubMed ID: 3895459
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemodynamic and electrocardiographic effects of verapamil in ischemic cardiopathy].
    Aquaro G; Belli R; Ravera A; Rey L; Possavino G; Trucco G; Pavia M; Idone P
    Boll Soc Ital Cardiol; 1981; 26(12):2143-6. PubMed ID: 7185381
    [No Abstract]   [Full Text] [Related]  

  • 27. The place of beta-blockers in cardiovascular medicine.
    Cruickshank JM
    Cardiologia; 1995 Nov; 40(11):829-43. PubMed ID: 8706060
    [No Abstract]   [Full Text] [Related]  

  • 28. [Proscillaridine A in association with theophylline, ethylcrotylbarbituric acid and mecloxamine in clinical practice].
    Meschino S; Meoni S; Massari F; Fontana F
    Atti Accad Fisiocrit Siena Med Fis; 1967; 16(1):719-59. PubMed ID: 5630270
    [No Abstract]   [Full Text] [Related]  

  • 29. [Beta-adrenoblockaders and calcium antagonists in the treatment of patients with ischemic heart disease combined with hypertension].
    Andrushchenko EV; Chmir VP; Krasovskaia EA; Malanchuk TA; Polishchuk II; Iashchenko OB
    Vrach Delo; 1990 Nov; (11):35-8. PubMed ID: 1983050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term study with Stenoptin in general practice].
    Kessler H
    Med Welt; 1980 Jan; 31(4):149-51. PubMed ID: 6154224
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical trials of the effect of verapamil in subjects with angina pectoris].
    De Liperi E; Coli R; Brunori F; Singer MT
    Minerva Med; 1970 Dec; 61(97):5562-73. PubMed ID: 5494125
    [No Abstract]   [Full Text] [Related]  

  • 32. Calcium blocker therapy in cardiovascular disease.
    Assey ME
    J S C Med Assoc; 1982 Jul; 78(7):365-8. PubMed ID: 6956777
    [No Abstract]   [Full Text] [Related]  

  • 33. [Verapamil and hypertension--(multicenter study of the efficacy and tolerance of delayed-action verapamil in the treatment of essential hypertension)].
    Kreuter U; Mühlemann M; Vogt E; Wohlwend MC
    Rev Med Suisse Romande; 1990 Jun; 110(6):551-8. PubMed ID: 2195624
    [No Abstract]   [Full Text] [Related]  

  • 34. [Action of verapamil in coronariopathic patients. Evaluation using the ergometric test].
    Duarte GM; Ribeiro LG; Coelho W; Thevenard R; Souza PJ; Gonçalves MA; Carneiro RD; Luna RL
    Arq Bras Cardiol; 1976 Aug; 29(4):338-45. PubMed ID: 1008726
    [No Abstract]   [Full Text] [Related]  

  • 35. [Calcium antagonists and primary prevention of coronary disease].
    Rehnqvist N
    Arch Mal Coeur Vaiss; 1995 Sep; 88 Spec No 4():13-6. PubMed ID: 7503620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recent data on coronary dilators].
    Duchêne-Marullaz P; Lavarenne J
    Actual Pharmacol (Paris); 1968; 21():65-116. PubMed ID: 4890107
    [No Abstract]   [Full Text] [Related]  

  • 37. [Nitrendipine in patients with coronary disease and hypertension. Acute and long-term effects on hemodynamics and myocardial ischemia].
    Schmoeckel M; Arendt RM; Hauck R; Schultheiss HP
    Fortschr Med; 1988 Dec; 106(35):715-8. PubMed ID: 3235012
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of coronary disease patients with Verapamil (Isoptin)].
    Buttolo R; Nardoni A
    Minerva Cardioangiol; 1972 Jan; 20(1):7-21. PubMed ID: 4258309
    [No Abstract]   [Full Text] [Related]  

  • 39. [The use of propranolol and verapamil in patients with ischemic heart disease].
    Chizh VD
    Vrach Delo; 1990 Feb; (2):15-8. PubMed ID: 2339541
    [No Abstract]   [Full Text] [Related]  

  • 40. [Role of vasoactive substances in the treatment of cardiovascular diseases].
    Heine H; Schmidt H; Faulhaber HD; Anders G
    Dtsch Gesundheitsw; 1972 Nov; 27(44):2090-3. PubMed ID: 4405750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.